Advertisement

Article not rated

Vol. 26 - Num. 103

Evidence based Pediatrics

Atropine eyedrops can prevent the onset and delay the progression of myopia in children

Elena Pérez Gonzáleza, Victoria Martínez Rubiob

aServicio de Pediatría. Hospital Universitario Virgen de la Macarena. Sevilla.
bPediatra. CS Los Fresnos. Torrejón de Ardoz. Madrid. España.

Correspondence: E Pérez . E-mail: pg.elena@gmail.com

Reference of this article: Pérez González E, Martínez Rubio V. Atropine eyedrops can prevent the onset and delay the progression of myopia in children . Rev Pediatr Aten Primaria. 2024;26:311-3. https://doi.org/10.60147/a0e2a88f

Published in Internet: 27-09-2024 - Visits: 632

Abstract

Authors´ conclusions: nightly use of 0.05% atropine eyedrops among children aged 4 to 9 years without myopia resulted in a significantly lower incidence of myopia and lower percentage of participants with fast myopic shift at 2 years.

Reviewers´ commentary: this study, of adequate design and quality, concludes that atropine in low concentration helps prevent the onset and rapid progression of myopia in high-risk children, with few side effects. Long-term follow-up is pending to assess adequate follow-up time and possible rebound effect after suspension.

Keywords

Atropine Child Myopia Prevention

Note:

Este artículo se publica simultáneamente con la revista electrónica Evidencias en Pediatría (www.evidenciasenpediatria.es). 

Comments

This article has no comments yet.